HMG-1 rediscovered as a cytokine

Shock

Volumn 15, Issue 4, 2001, Pages 247-253

  Yang, Huan ^a   Wang, Haichao ^a   Tracey, Kevin J ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Cytokine; Endotoxemia; High mobility group 1; Inflammation; Lipopolysaccharide; Sepsis; Shock; Tumor necrosis factor

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; AUTACOID; CARRIER PROTEIN; CYTOKINE; ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP PROTEIN; IMMUNOGLOBULIN RECEPTOR; INSECT PROTEIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADENOHYPOPHYSIS; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; CYTOLOGY; DROSOPHILA MELANOGASTER; DRUG EFFECT; ENDOTOXEMIA; GENETICS; HUMAN; LUNG; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; MONOCYTE; MULTIGENE FAMILY; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SECRETION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; VERTEBRATE;

ACUTE-PHASE REACTION; AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CYTOKINES; DROSOPHILA MELANOGASTER; ENDOTOXEMIA; ENDOTOXINS; HIGH MOBILITY GROUP PROTEINS; HMGB1 PROTEIN; HUMANS; INFLAMMATION MEDIATORS; INSECT PROTEINS; INTERLEUKIN-1; LUNG; MACROPHAGES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MONOCYTES; MULTIGENE FAMILY; PITUITARY GLAND, ANTERIOR; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, IMMUNOLOGIC; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA; VERTEBRATES;

EID: 0035316744     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115040-00001     Document Type: Review

References (106)

1. Schumann RR, Leong SR, Flaggs GW, et al.: Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431, 1990.
2. Yu B, Hailman E, Wright SD: LPS binding protein (LBP) and sCD 14 catalyze exchange of phospholipids. J Clin Investig 99:315-324, 1997.
3. Yu B, Wright SD: Catalytic properties of lipopolysaccharide (LPS)-binding protein (LBP): I. Transfer of LPS to soluble CD 14. J Biol Chem 271:4100-4105, 1996.
4. Brightbill HD, Modlin RL : Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology 101:1-10, 2000.
5. Means TK, Golenbock DT, Fenton MJ: The biology of Toll-like receptors. Cytokine Growth Factor Rev 11:219-232, 2000.
6. Qureshi ST, Lariviere L, Leveque G, et al.: Endotoxin-tolerant mice have mutations in Toll-like receptor 4. J Exp Med 189:615-625, 1999.
7. Chow JC, Young DW, Golenbock DT, et al.: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689-10692, 1999.
8. Bernhagen J, Calandra T, Mitchell RA, et al.: Macrophage migration inhibitory factor (MIF) is a pituitary-derived cytokine and potentiates lethal endotoxaemia. Nature 365:756-759, 1993.
9. Zhang M, Tracey KJ: Tumor necrosis factor. In Thomas AW (ed): The Cytokine Handbook, 3rd edition. Chap. 19, London: Academic Press, 1998, pp 517-548.
10. Tracey KJ, Cerami A: Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9:317-343, 1993.
11. Tracey KJ, Beutler B, Lowry SF, et al.: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
12. Bone RC: The pathogenesis of sepsis. Ann Intern Med 115:457-469, 1991.
13. Nathan CF: Secretory products of macrophages. J Clin Investig 79:319-326, 1987.
14. Wang H, Tracey KJ: Tumor necrosis factor, interleukin-6, macrophage migration inhibitory factor, and macrophage inflammatory protein-1 in inflammation. In Gallin JI, Snyderman R (ed): Inflammation: Basic Principle and Clinical Correlates, 3rd edition. Philadelphia: Lippincott, Williams & Wilkins, 1999, pp 471-485.
15. Tracey KJ, Fong Y, Hesse DG, et al.: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664, 1987.
16. Amiot F, Fitting C, Tracey KJ, et al.: Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice. Mol Med 3:864-875, 1997.
17. Wang H, Bloom O, Zhang M, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251, 1999.
18. Ombrellino M, Wang H, Ajemian MS, et al.: Increased serum concentrations of high-mobility-group protein 1 in haemorhagic shock. Lancet 354:1446-1447, 2000.
19. Andersson U, Wang H, Palmblad K, et al.: HMG-1 stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570, 2000.
20. Yang H, Wang H, Che J, et al.: High mobility group-1 (HMG-1) protein stimulates tumor necrosis factor (TNF), interleukin-1 beta (IL-1beta) and interleukin-6 (IL-6) mRNA and protein release in human peripheral blood mononuclear cells (PBMCs). FASEB J 14:A181, 2000.
21. Wang H, Vishnubhakat JM, Bloom O, et al.: Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126:389-392, 1999.
22. Goodwin GH, Sanders C, Johns EW: A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 38:14-19, 1973.
23. Bustin M, Lehn DA, Landsman D: Structural features of the HMG chromosomal proteins and their genes. Biochem Biophys Acta 1049:231-243, 1990.
24. Bustin M, Reeves R: High mobility group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54:35-100, 1996.
25. Boonyaratanakornkit V, Melvin V, Prendergast P, et al.: High mobility group chromatin proteins-1 and -2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol 18:4471-4487, 1998.
26. Melvin VS, Edwards DP: Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids 64:576-586, 1999.
27. Johns EW: The HMG Chromosomal Proteins. London: Academic Press, 1982.
28. Walker JM, Gooderham K, Hastings JR, et al.: The primary structures of non-histone chromosomal proteins HMG 1 and 2. FEBS Lett 122:264-270, 1980.
29. Tsuda KI, Kikuchi M, Mori K, et al.: Primary structure of non-histone protein HMG 1 revealed by the nucleotide sequence. Biochemistry 27:6159-6163, 1988.
30. Pentecost B, Dixon GH: Isolation and partial sequence of bovine cDNA clones for the high-mobility-group protein (HMG-1). Biosci Rep 4:49-57, 1984.
31. Yotov WV, St.-Arnaud R: Nucleotide sequence of a mouse cDNA encoding the nonhistone chromosomal high mobility group protein-1 (HMG1). Nucleic Acid Res 11:3516, 1992.
32. Stros M, Dixon GH: A retropseudogene for non-histone chromosomal protein HMG-1. Biochem Biophys Acta 1172:231-235, 1993.
33. Wen L, Huang JK, Johnson BH, et al.: A human placental cDNA clone that encodes non-histone chromosomal protein HMG-1. Nucleic Acid Res 17: 1199-1214, 1989.
34. Weir HM, Kraulis PJ, Hill CS, et al.: Structure of the HMG box motif in the B-domain of HMG1. EMBO J 12:1311-1319, 1993.
35. Hardman CH, Broadhurst RW, Raine ARC, et al.: Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three-and four-dimensional NMR spectroscopy. Biochemistry 34:16596-16607, 1995.
36. Bianchi ME, Beltrame M, Paonessa G: Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243:1056-1059, 1989.
37. Landsman D, Bustin M: A signature for the HMG-1 box DNA-binding proteins. Bioessays 15:539-546, 1993.
38. Ner SS: HMGs everywhere. Curr Biol 2:208-210, 1992.
39. Baxevanis AD, Landsman D: The HMG-1 box protein family: classification and functional relationship. Nucleic Acids Res 23:1604-1613, 1995.
40. Sparrow DB, Wells RE Jr: Sequence of a cDNA encoding chicken high-mobility-group protein-2. Gene 114:289-290, 1992.
41. Maher JF, Nathans D: Multivalent DNA-binding properties of the HMG-I proteins. Proc Natl Acad Sci USA 93:6717-6720, 1996.
42. Pentecost BT, Wright JM, Dixon GH: Isolation and sequence of cDNA clones coding for a member of the family of high mobility group proteins (HMG-T) in trout and analysis of HMG-T-mRNA's in trout tissues. Nucleic Acids Res 13:4871-4888, 1985.
43. Stros M, Nishikawa S, Dixon GH: cDNA sequence and structure of a gene encoding trout testis high-mobility-group-1 protein. Eur J Biochem 225:581-591, 1994.
44. Kinoshita M, Hatada S, Asashima M, et al.: HMG-X, a Xenopus gene encoding an HMG 1 homolog, is abundantly expressed in the developing nervous system. FEBS Lett 352:191-196, 1994.
45. Ner SS, Churchill ME, Searles M, et al.: dHMG-Z, a second HMG-1-related protein in Drosophila melanogaster. Nucleic Acids Res 21:4369-4371, 1993.
46. Ner SS, Travers AA: HMG-D, the Drosophila melanogaster homologue of HMG-1 protein, is associated with early embryonic chromatin in the absence of histone H1. EMBO J 13:1817-1822, 1994.
47. Goodwin GH, Wright CA, Jones EW: The characterization of 1SF monomer nucleosomes from hen oviduct and the partial characterization of a third HMG14/17-like in such nucleosomes. Nucleic Acids Res 9:2761-2775, 1981.
48. Dimov SI, Alexandrova EA, Beltchev BG: Differences between some properties of acetylated and nonacetylated forms of HMG1 protein. Biochem Biophys Res Commun 166:819-826, 1990.
49. Wisniewski JR, Szegniew Z, Petty I, et al.: Constitutive phosphorylation of the acidic tails of the high mobility group 1 proteins by casein kinase II alters their conformation, stability, and DNA binding specificity. J Biol Chem 274: 20116-20122, 1999.
50. ++-dependent protein kinase from pig testis. Biochem J 227:271-276, 1985.
51. Boffa LC, Sterner R, Vidali G, et al.: Post-synthetic modifications of nuclear proteins high mobility proteins are methylated. Biochem Biophys Res Commun 89:1322-1327, 1979.
52. Tanuma S, Yaki T, Johnson GS: Endogenous ADP ribosylation of high mobility group proteins 1 and 2 and histone H1 following DNA damage in intact cells. Arch Biochem Biophys 237:38-42, 1985.
53. Chao YB, Scovell WM, Yan SB: High mobility group protein, HMG-1, contains insignificant glycosyl modification. Protein Sci 3:2452-2454, 1994.
54. Wolffe AP: Architectural transcription factors. Science 264:1100-1101, 1994.
55. Prasad S, Thakur MK: In vitro acetylation of the liver HMG non-histone proteins and its modulation by spermine and dexamethasone during aging of rats. Mol Biol Rep 13:221-224, 1989.
56. Mosevitsky MI, Novitskaya VA, Iogannsen MG, et al.: Tissue specificity of nucleo-cytoplasmic distribution of HMG 1 and HMG 2 proteins and their probable functions. Eur J Biochem 185:303-310, 1989.
57. Hughes EN, Engelsberg BN, Billings PC: Purification of nuclear proteins that bind to cisplatin-damaged DNA. J Biol Chem 267:13520-13527, 1992.
58. Ohndorf UM, Rould MA, He Q, et al.: Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature 399:708-712, 1999.
59. Kawahara N, Tanaka T, Yokomizo A, et al.: Enhanced co-expression of thioredoxin and high mobility group protein 1 gene in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. Cancer Res 56:5330-5333, 1996.
60. Pil PM, Lippard SJ: Specific binding of chromosomal protein HMG-1 to DNA damaged by the anticancer drug cisplatin. Science 256:234-237, 1992.
61. Jantzen HM, Admon A, Bell SP, et al.: Nuclear transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins. Nature 344: 830-836, 1990.
62. Bachvarov D, Moss T: The RNA polymerase I transcription factor xUBF contains 5 tandemly repeated HMG homology boxes. Nucleic Acids Res 19: 2331-2335, 1991.
63. Love JJ, Li X, Case DA, Giese K, et al.: Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376:791-795, 1995.
64. Van de Wetering M, Oosterwegel M, Dooijes, et al.: Identification and cloning of TCF-1, a T-lymphocyte-specific transcription factor containing a sequence B specific HMG box. EMBO J 10:123-132, 1991.
65. Sinclair AH, Berta P, Palmer MS, et al.: A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240-244, 1990.
66. Kelly M, Burke J, Smith M, Klar A, et al.: Four mating-type genes control sexual differentiation in the fission yeast. EMBO J 7:1537-1547, 1988.
67. Staben C, Yanofsky C: Neurospora crassa a mating-type region. Proc Natl Acad Sci USA 87:4917-4921, 1990.
68. Nasrin N, Buggs C, Kong XF, et al.: DNA-binding properties of the product of the testis-determining gene and a related product. Nature 354:317-320, 1991.
69. Sugimoto A, Iino Y, Maeda T, et al.: Schizosaccharomyces pombe ste11+ encodes a transcription factor with an HMG motif that is critical regulator of sexual development. Gene Dev 5:1990-1999, 1991.
70. Calogero S, Grassi F, Aguzzi A, et al.: The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycemia in newborn mice. Nat Genet 22:276-280, 1999.
71. Merenmies J, Pihlaskari R, Laitinen J, et al.: 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth: amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 266:16722-16729, 1991.
72. Daston MM, Ratner N: Expression of P30, a protein with adhesive properties, in Schwann cells and neurons of the developing and regenerating peripheral nerve. J Cell Biol 112:1229-1239, 1991.
73. Salmivirta M, Rauvala H, Elenius K, et al.: Neunte growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res 200:444-451, 1992.
74. Rauvala H, Pihlaakari R: Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J Biol Chem 262:16625-16635, 1987.
75. Rauvala H, Merenmies J, Pihlaskari R, et al.: The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons. J Biol Chem 107:2292-2305, 1988.
76. Melloni E, Sparatore B, Patrone M, et al.: Identity in molecular structure between "differentiation enhancing factor" of murine erythroleukemia cells and the 30-kD heparin-binding protein of developing rat brain. Biochem Biophys Res Commun 210:82-89, 1995.
77. Sparatore B, Melloni E, Patrone M, et al.: A 6-kDa protein homologous to the N-terminus of the HMG-1 protein promoting stimulation of murine erythroleukemia cell differentiation. FEBS Lett 386:95-98, 1996.
78. Passalacqua M, Zicca A, Sparatore B, et al.: Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation. FEBS Lett 400:275-279, 1997.
79. Melloni E, Sparatore B, Patrone M, et al.: Extracellular release of the "differentiation enhancing factor," a HMG1 protein type, is an early step in murine erythroleukemia cell differentiation. FEBS Lett 368:466-470, 1995.
80. Sparatore B, Passalacqua M, Patrone M, et al.: Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. Biochem J 320:253-256, 1996.
81. Hofmann MA, Drury S, Fu C, et al.: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901, 1999.
82. Hori O, Brett J, Slattery T, et al.: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J Biol Chem 270: 25752-25761, 1995.
83. Miyata T, Hori O, Zhang J, et al.: The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. J Clin Investig 98:1088-1094, 1996.
84. Yan SD, Schmidt AM, Anderson GM, et al.: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/ binding proteins. J Biol Chem 269:9889-9897, 1994.
85. Lander HM, Tauras JM, Ogiste JS, et al.: Activation of the receptor for advanced glycation end products triggers a p21ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810-17814, 1997.
86. Neeper M, Schmidt AM, Brett J, et al.: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992.
87. Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274:19919-19924, 1999.
88. Taguchi A, Blood DC, Toro GD, et al.: Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases. Nature 405:354-360, 2000.
89. Mistry AR, Falciola L, Monaco L, et al.: Recombinant HMG1 protein produced in Pichia pastoris: a nonviral gene delivery agent. Biotechniques 22:718-729, 1997.
90. Hacker H: Signal transduction pathways activated by CpG-DNA. Curr Top Microbiol Immunol 247:77-92, 2000.
91. Vassali JD, Sappino AP, Belin D: The plasminogen activator/plasmin system. J Clin Investig 88:1067-1072, 1991.
92. Parkkinen J, Rauvala H: Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. J Biol Chem 266:16730-16735, 1991.
93. Parkkinen J, Raulo E, Merenmies J, et al.: Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. J Biol Chem 268:19726-19738, 1993.
94. Brickman, JM, Adam M, Ptashine M: Interactions between an HMG-1 protein and members of the Rel family. Proc Natl Acad Sci USA 96:10679-10683, 1999.
95. Yamamura J, Takada Y, Goto M, et al.: High mobility group-like protein in bovine milk stimulates the proliferation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 261:113-117, 1999.
96. Sheflin LG, Fucile NW, Spaulding SW: The specific interactions of HMG-1 and 2 with negatively supercoiled DNA are modulated by their acidic C-terminal domains and involve cysteine residues in their HMG 1/2 boxes. Biochemistry 32:3238-3248, 1993.
97. Payet D, Travers A: The acidic tail of the high mobility group protein HMG-D modulates the structural selectivity of DNA binding. J Mol Biol 266:66-75, 1997.
98. Aizawa S, Nishino H, Saito K, et al.: Stimulation of transcription in cultured cells by high mobility group protein essential role of the acidic carboxyl-terminal region. Biochemistry 33:14690-14695, 1994.
99. Abraham E, Arcaroli J, Carmody A, et al.: HMG-1 as a mediator of acute lung injury. J Immunol 165:2950-2954, 2000.
100. Morse JH, Barst RJ, Fotino M, et al.: Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone. Clin Exp Immunol 106:389-395, 1996.
101. Ayer LM, Rubin RL, Dixon GH, et al.: Antibodies to HMG proteins in patients with drug-induced autoimmunity. Arthritis Rheumatism 37:98-103, 1994.
102. Jung F, Neuer G, Bautz FA: Antibodies against a peptide sequence located in the linker region of the HMG-1/2 box domains in sera from patients with juvenile rheumatoid arthritis. Arthritis Rheumatism 40:1803-1809, 1997.
103. Wittemann B, Neuer G, Michels H, et al.: Auto-antibodies to non-histone chromosomal proteins HMG-1 and HMG2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheumatism 33:1378-1383, 1990.
104. Sobajima J, Ozaki S, Uesugi H, et al.: High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 44:867-873, 1999.
105. Bustin M, Einck L, Reisch J: Auto-antibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune disease. Science 215:1245-1247, 1982.
106. Ayer LM, Senecal J, Martin L, et al.: Antibodies to high mobility group (HMG) proteins in systemic sclerosis. J Rheumatol 21:2071-2075, 1994.